INDORAMA NSE filing

Indo Rama Synthetics Q2 FY27 Investor Presentation Released

The RealCase readMedium impact Positive

Indo Rama Synthetics released its Q2 FY27 Investor Presentation. Q2 FY27 PAT rose to ₹74.1 crore from ₹24.6 crore in Q2 FY26. H1 FY27 PAT increased to ₹137.8 crore from ₹77.3 crore in H1 FY26. The company plans a ₹200 crore expansion for specialty filament and fibre production.

Why it matters

The positive financial results and the planned expansion are material for the company's future performance, impacting investor sentiment and strategic direction. However, the expansion is still in the planning/early stages.

The market read

The company reported improved financial performance with significant year-on-year growth in PAT for both Q2 and H1 FY27. The planned expansion also indicates a positive outlook for future growth.

Indo Rama Synthetics (India) Limited has released its Investor Presentation for the second quarter and half-year ended September 30, 2026. The presentation, shared with analysts and investors, details the unaudited financial results for the period.

The company's consolidated financial performance for Q2 FY27 showed a total income of ₹1,344.0 crore, an increase from ₹1,222.4 crore in Q2 FY26. EBITDA for the quarter stood at ₹117.7 crore, up from ₹80.4 crore in the same period last year. Profit After Tax (PAT) for Q2 FY27 was ₹74.1 crore, a significant rise from ₹24.6 crore in Q2 FY26. For the half-year ended September 30, 2026 (H1 FY27), total income was ₹2,284.2 crore, compared to ₹2,530.9 crore in H1 FY26. EBITDA for H1 FY27 was ₹225.7 crore, an improvement from ₹180.7 crore in H1 FY26. PAT for H1 FY27 was ₹137.8 crore, up from ₹77.3 crore in H1 FY26.

The company also highlighted its expansion plans, including an approximately ₹200 crore investment for expanding specialty filament and fibre production at its Butibori facility. Operations are expected to commence in CY27, with full benefits in FY27-28. This expansion is projected to increase EBITDA by approximately 20% and is funded through term loans and internal accruals, with a payback period of less than 2 years.

Indo Rama Synthetics continues to focus on improving its operational efficiency, cost optimization, and expanding its specialty polyester portfolio. The company is leveraging its strong parentage from Indorama Ventures Public Company Limited (IVL), its integrated operations, and a diversified product mix to drive sustainable growth.

Filing to action

What to do with a filing like this

Indo Rama Synthetics (India) Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Indo Rama Synthetics (India) Limited. Read the original for the full detail.

View original filing